BYBo Yu

Bo Yu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bo Yu has a total of 85 co-authors. Here are the top co-authors by number of shared publications:

  • Congzhou Liu

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center

    6 shared publications
  • David N. Fredricks

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center , Seattle, Washington

    6 shared publications
  • Jacques Cohen

    Reprogenetics LLC, Livingston, New Jersey, United States of America

    3 shared publications
  • Mario Vega

    Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine, Bronx, New York

    3 shared publications
  • Shuying Liang

    Department of Obstetrics and Gynecology, University of Washington

    3 shared publications
  • Stephanie L. Battle

    Department of OBGYN, University of Washington School of Medicine, Seattle, Washington, United States of America

    3 shared publications

Latest Publications

  • Open Access

    Design and Evaluation of Fluorescent gRNAs for Visibility Improvement in dCas9-Mediated Live-Cell Imaging

    by David Connor Hawke, Bo Yu

    Live-cell nuclear imaging continues to be limited by the number of fluorescent moieties that may be recruited to the DNA locus of interest. Major advances in dCas9-based live-cell imaging have been made using plasmid-based expression systems that integrate many protein fluorophores into the dCas9 fluorescent ribonucleoprotein (fRNP) complex to increase the visibility of the resulting DNA labels. The dependence on exogenous DNA plasmids, however, precludes these strategies from applications where precise control of fRNP presence is necessary or possible plasmid integration into the genome is unacceptable. In this study, we evaluated the capacity for fluorescent guide RNA (gRNA) to improve the visibility of cellular DNA labels during live-cell imaging, bypassing the need for complex fluorescent protein expression and foreign DNA plasmid delivery. Both CRISPR RNA (crRNA) and trans-activating crRNA (tracrRNA) components of the gRNA were modified with terminal cyanine 3 (Cy3) fluorophores before assembly into fRNP, and the impact on the brightness and signal-to-background (SNB) of the resulting DNA labels was evaluated at two different genomic loci: a repeat-rich Chr3 locus and chromosome telomeres. We further explored the visibility of DNA labeled with a “split” fRNP constructed from two individual tracrRNA fragments, rather than the complete 86 nt tracrRNA sequence, in order to reduce the costs and turnaround time of tracrRNA synthesis and to increase the terminal ends available for fluorophore modification. The 86 nt tracrRNA configuration bearing two terminal Cy3 modifications to both the crRNA and tracrRNA resulted in the greatest improvement to label visibility with a 190% increase in brightness and a 60% increase in SNB for both loci, on average, in comparison to the previously published fRNP containing only one Cy3 on the crRNA. The split tracrRNA fRNP was capable of labeling both genomic loci with varying success, imparting a maximum brightness improvement of 153% and an SNB improvement of 49% to Chr3 labeling, however, with no significant gains to brightness and 41% improved SNB for telomeres. For both the designs, label visibility improved consistently with additional fluorescence modification of the gRNA, indicating that the modifications were well tolerated, and further enhancement of gRNA fluorescence may continue to improve label visibility during live-cell imaging.

  • Developmental potential of zygotes without pronucleus (0PN) and pregnancy outcomes after single euploid blastocyst transfers

    by Jeong Hee Moon, Jiaqi Zhang, Bo Yu

    Objective To evaluate the developmental potential of zygotes without pronucleus (0PN) and to examine the pregnancy outcomes of euploid blastocysts derived from these zygotes. Methods A total of 4580 fresh autologous preimplantation genetic testing for aneuploidy (PGT-A) cycles from 2634 patients at a single academic center from April 2016 to December 2022 with at least one 0PN at the time of fertilization check (16–19 hours post insemination) were included in the study. Results Of all 0PNs (n = 9345), 70.4% reached the cleavage stage, while only 5.3% of the cleaved embryos reached blastocyst stage and met biopsy criteria. These rates were significantly lower than those from the 2PNs (n = 32086, 98.7% cleavage, and 43.6% biopsied blastocyst rates, p < 0.05). Logistic regression model showed that 2PNs were 19.6 times more likely to result in biopsied blastocysts than 0PNs (p < 0.05). Of the biopsied blastocysts, 39% and 45% were euploid from the 0PN (n = 349) and 2PN (n = 13,975) group, respectively (p < 0.05). After single euploid frozen blastocyst transfers (n = 27 and 1695 in the 0PN and 2PN groups, respectively), no statistical significance was observed in live birth, clinical pregnancy, biochemical pregnancy, and spontaneous pregnancy loss rates between these two groups. Conclusion Compared to 2PN zygotes, the 0PNs showed lower developmental potential, including lower blastocyst formation and euploidy rates. However, euploid blastocysts from either cohort resulted in similar live birth rates, indicating a small percentage of 0PN zygotes can result in normal blastocysts and live births presenting additional reproductive opportunities for patients lacking alternatives.


  • Open Access

    Identification of fallopian tube microbiota and its association with ovarian cancer

    by Bo Yu, Congzhou Liu, Sean C Proll, Enna Manhardt, Shuying Liang, Sujatha Srinivasan, Elizabeth Swisher, David N Fredricks

    Investigating the human fallopian tube (FT) microbiota has significant implications for understanding the pathogenesis of ovarian cancer (OC). In this large prospective study, we collected swabs intraoperatively from the FT and other surgical sites as controls to profile the microbiota in the FT and to assess its relationship with OC. Eighty-one OC and 106 non-cancer patients were enrolled and 1001 swabs were processed for 16S rRNA gene PCR and sequencing. We identified 84 bacterial species that may represent the FT microbiota and found a clear shift in the microbiota of the OC patients when compared to the non-cancer patients. Of the top 20 species that were most prevalent in the FT of OC patients, 60% were bacteria that predominantly reside in the gastrointestinal tract, while 30% normally reside in the mouth. Serous carcinoma had higher prevalence of almost all 84 FT bacterial species compared to the other OC subtypes. The clear shift in the FT microbiota in OC patients establishes the scientific foundation for future investigation into the role of these bacteria in the pathogenesis of OC.


  • Open Access

    Identification of fallopian tube microbiota and its association with ovarian cancer: a prospective study of intraoperative swab collections from 187 patients

    by Bo Yu, Congzhou Liu, Sean Proll, Enna Mannhardt, Shuying Liang, Sujatha Srinivasan, Elizabeth M. Swisher, David N. Fredricks

    Investigating the human fallopian tube (FT) microbiota has significant implications for understanding the pathogenesis of ovarian cancer (OC). In this large prospective study, we collected swabs intraoperatively from the FT and other surgical sites as controls to profile the microbiota in the FT and to assess its relationship with OC. 81 OC and 106 non-cancer patients were enrolled and 1001 swabs were processed for 16S rRNA gene PCR and sequencing. We identified 84 bacterial species that may represent the FT microbiota and found a clear shift in the microbiota of the OC patients when compared to the non-cancer patients. Of the top 20 species that were most prevalent in the FT of OC patients, 60% were bacteria that predominantly reside in the gastrointestinal tract, while 30% normally reside in the mouth. Serous carcinoma had higher prevalence of almost all 84 FT bacterial species compared to the other OC subtypes. The clear shift in the FT microbiota in OC patients establishes the scientific foundation for future investigation into the role of these bacteria in the pathogenesis of ovarian cancer.

  • DISCORDANT NON-INVASIVE PGT-A RESULTS AND CLINICAL OUTCOME

    by Eliza Curnow, Ginny L. Ryan, Bo Yu

  • Vaginal Bacteria Elicit Acute Inflammatory Response in Fallopian Tube Organoids

    by Bo Yu, Stephen McCartney, Susan Strenk, Daniel J. Valint, Congzhou Liu, Catherine L. Haggerty, David N. Fredricks

    To facilitate in vitro mechanistic studies in pelvic inflammatory disease and subsequent tubal factor infertility, we sought to establish patient tissue derived fallopian tube (FT) organoids and to study their inflammatory response to acute vaginal bacterial infection. FT tissues were obtained from four patients after salpingectomy for benign gynecological diseases. We introduced acute infection in the FT organoid culture system by inoculating the organoid culture media with two common vaginal bacterial species, Lactobacillus crispatus and Fannyhessea vaginae. The inflammatory response elicited in the organoids after acute bacterial infection was analyzed by the expression profile of 249 inflammatory genes. Compared to the negative controls that were not cultured with any bacteria, the organoids cultured with either bacterial species showed multiple differentially expressed inflammatory genes. Marked differences were noted between the Lactobacillus crispatus infected organoids and those infected by Fannyhessea vaginae. Genes from the C-X-C motif chemokine ligand (CXCL) family were highly upregulated in Fannyhessea vaginae infected organoids. Flow cytometry showed that immune cells quickly disappeared during the organoid culture, indicating the inflammatory response observed with bacterial culture was generated by the epithelial cells in the organoids. In summary, we have shown that patient tissue derived FT organoids respond to acute bacterial infection with upregulation of inflammatory genes specific to different vaginal bacterial species. FT organoids is a useful in vitro model system to study the host-pathogen interaction during bacterial infection.


  • Open Access

    Identification of fallopian tube microbiota and its association with ovarian cancer: a prospective study of intraoperative swab collections from 187 patients

    by Bo Yu, Congzhou Liu, Sean Proll, Enna Mannhardt, Shuying Liang, Sujatha Srinivasan, Elizabeth M. Swisher, David N. Fredricks

    Investigating the human fallopian tube (FT) microbiota has significant implications for understanding the pathogenesis of ovarian cancer (OC). In this large prospective study, we collected swabs intraoperatively from the FT and other surgical sites as controls to profile the microbiota in the FT and to assess its relationship with OC. 81 OC and 106 non-cancer patients were enrolled and 1001 swabs were processed for 16S rRNA gene PCR and sequencing. We identified 84 bacterial species that may represent the FT microbiota and found a clear shift in the microbiota of the OC patients when compared to the non-cancer patients. Of the top 20 species that were most prevalent in the FT of OC patients, 60% were bacteria that predominantly reside in the gastrointestinal tract, while 30% normally reside in the mouth. Serous carcinoma had higher prevalence of almost all 84 FT bacterial species compared to the other OC subtypes. The clear shift in the FT microbiota in OC patients establishes the scientific foundation for future investigation into the role of these bacteria in the pathogenesis of ovarian cancer. SUMMARY: Introduction: Investigating the human fallopian tube (FT) microbiota has significant implications for understanding the pathogenesis of ovarian cancer (OC), pelvic inflammatory disease, and tubal ectopic pregnancy, as well as normal fertilization. Several studies have provided evidence that the FT may not be sterile, but rigorous controls are needed to assess the microbiota in low biomass samples. In this large prospective study, we collected swabs intraoperatively from the FT and other surgical sites as controls to profile the microbiota in the FT and to assess its relationship with OC. Methods: We collected swabs from the cervix, FT, ovarian surfaces, and paracolic gutters of patients, and from laparoscopic ports and air in the operating room. Surgical indications included known or suspected ovarian cancers, risk-reducing salpingo-oophorectomies due to genetic risk, and benign gynecological disorders. DNA was extracted from the swabs and the bacterial concentrations were quantified using broad-range bacterial quantitative PCR. Bacterial composition was characterized using amplicon PCR targeting the V3–V4 hypervariable region of the 16S rRNA gene combined with next generation sequencing. Multiple negative controls and filtering approaches were used to differentiate FT microbiota from likely contaminant sequences. Presence of the bacterial taxa in both the cervical and FT sample set was required to identify ascending genital tract bacteria. Results: A total of 81 ovarian cancer patients and 106 non-cancer patients were enrolled and 1001 swabs were processed. The bacterial concentrations of FT and ovarian surfaces averaged 2.5 copies of 16S rRNA genes/μl of DNA (standard deviation, SD 4.6), similar to the paracolic gutter and higher than the controls (p-value < 0.001). We identified 84 bacterial species that may represent the FT microbiota. After ranking the FT bacteria based on the prevalence difference, we found a clear shift in the microbiota of the OC patients when compared to the non-cancer patients. Of the top 20 species that were most prevalent in the FT of OC patients, 60% were bacteria that predominantly reside in the gastrointestinal tract, such as Klebsiella, Faecalibacterium prausnitzii, Ruminiclostridium , and Roseburia , while 30% normally reside in the mouth, such as Streptococcus mitis, Corynebacterium simulans/striatum , and Dialister invisus . On the contrary, vaginal bacterial species are more prevalent in the FT from non-cancer patients, representing 75% of the top 20 bacterial species that are most prevalent in non-cancer patients. Serous carcinoma had higher prevalence of almost all 84 FT bacterial species compared to the other OC subtypes. Conclusion: In this large low biomass microbiota study using intraoperatively collected swabs, we identified a group of bacterial species that appear to reside in the FT across multiple participants. A higher prevalence of some of these bacterial species, especially those that normally reside outside the female genital tract, was noted in the FT from patients with OC, laying the scientific foundation to explore whether these bacteria may have a role in enhancing ovarian cancer risk.

  • Open Access

    Vaginal bacteria elicit acute inflammatory response in fallopian tube organoids: a model for pelvic inflammatory disease

    by Bo Yu, Stephen McCartney, Susan Strenk, Daniel J. Valint, Congzhou Liu, Catherine Haggerty, David Fredricks

    Objective: To facilitate in vitro mechanistic studies in pelvic inflammatory disease (PID) and subsequent tubal factor infertility, as well as ovarian carcinogenesis, we sought to establish patient tissue derived fallopian tube (FT) organoids and to study their inflammatory response to acute vaginal bacterial infection. Design: Experimental study. Setting: Academic medical and researchcenter. Patients: FT tissues were obtained from four patients after salpingectomy for benign gynecological diseases. Interventions: We introduced acute infection in the FT organoid culture system by inoculating the organoid culture media with two common vaginal bacterial species, Lactobacillus crispatus and Fannyhesseavaginae. Main Outcome Measures: The inflammatory response elicited in the organoids after acute bacterial infection was analyzed by the expression profile of 249 inflammatory genes. Results: Compared to the negative controls that were not cultured with any bacteria, the organoids cultured with either bacterial species showed multiple differentially expressed inflammatory genes. Marked differences were noted between the Lactobacillus crispatus infected organoids and those infected by Fannyhessea vaginae. Genes from the C-X-C motif chemokine ligand (CXCL) family were highly upregulated in F. vaginae infected organoids. Flow cytometry showed that immune cells quickly disappeared during the organoid culture, indicating the inflammatory response observed with bacterial culture was generated by the epithelial cells in the organoids. Conclusion: Patient tissue derived FT organoids respond to acute bacterial infection with upregulation of inflammatory genes specific to different vaginal bacterial species. FT organoids is a useful model system to study the host-pathogen interaction during bacterial infection which may facilitate mechanistic investigations in PID and its contribution to tubal factor infertility and ovarian carcinogenesis.


  • Congenital male genital malformations and paternal health: An analysis of the US claims data

    by Bo Yu, Chiyuan Amy Zhang, Tony Chen, Evan Mulloy, Gary M. Shaw, Michael L. Eisenberg

    Objective: To investigate the potential association between paternal health and male genital malformations in the offspring.Materials and methods: We analyzed data from 2007 to 2016 derived from the IBM MarketScan Research database, which reports on reimbursed private healthcare claims in the United States. The association between paternal comorbidities (defined as individual and combined measures) and genital malformations in male offspring was analyzed.Results: Of 376,362 male births, 22% of fathers had at least one component of metabolic syndrome (≥1) prior to conception. Totals of 2880 cases of cryptorchidism (0.77%) and 2651 cases of hypospadias (0.70%) were identified at birth. While 0.76% of sons born to fathers with no metabolic syndrome components were diagnosed with cryptorchidism, 0.82% of sons with fathers with multiple metabolic syndrome components had cryptorchidism. Similarly, 0.69% versus 0.88% of sons had hypospadias when fathers had 0 or 2+ components of metabolic syndrome. After adjusting for maternal and paternal factors, the odds of a son being diagnosed with hypospadias increased with two or more paternal metabolic syndrome components (Odds ratio [95% confidence interval]: 1.27 [1.10–1.47]). Specific components of paternal metabolic syndrome were not generally more associated with a son's genital malformations. When we performed a subgroup analysis where genital malformations were defined based on surgical correction, the association with hypospadias persisted.Conclusions: Fathers with multiple components of metabolic syndrome in the preconception period were observed to be at increased risk for having sons born with hypospadias. The results support the association between a man's andrological and overall health.